ACIP Recommends Updates to Pneumococcal Vaccination Guidelines
The update applies to patients who have not previously received a pneumococcal conjugate vaccine or whose previous vaccination history is unknown.
The update applies to patients who have not previously received a pneumococcal conjugate vaccine or whose previous vaccination history is unknown.
The randomized, double-blind trial enrolled a total of 1796 participants, of which 1727 completed the study.
Increased incidence of CAP was noted in stroke patients using PPIs.
The recall was initiated because the product had prolonged exposure to extremely cold weather during shipment.
Members of the PRISM trial group investigated whether CPAP administered immediately after major abdominal surgery could prevent postoperative morbidity.
Investigators conducted a quasi-experimental, retrospective study of adult patients with COVID-19 pneumonia to evaluate antibiotic use for community-acquired bacterial pneumonia following the release of guidelines.
Experts in infectious disease, pulmonology, cardiology, neurology, and psychiatry share their perspectives on the phenomenon that is long COVID-19.
Previously, the initial loading dose of Nuzyra for CABP was administered only by IV infusion.
Positive topline results were announced from two phase 3 studies evaluating V114, an investigational 15-valent pneumococcal conjugate vaccine, in pediatric patients for the prevention of invasive pneumococcal disease.